Mutation of the –RPVR– Propeptide Motif at C-Terminal of the Aα Chain Is Associated with Decreased Fibrinogen Expression

Stephen O. Brennan; Andrew D. Laurie

doi:10.1160/TH17-08-0578

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(01): 207-209
DOI: 10.1160/TH17-08-0578

Letter to the Editor

Schattauer GmbH Stuttgart

Mutation of the –RPVR– Propeptide Motif at C-Terminal of the Aα Chain Is Associated with Decreased Fibrinogen Expression

Authors

Stephen O. Brennan
Andrew D. Laurie

Abstract

Full Text

References

References
1 Doolittle RF. The molecular biology of fibrin. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H. , eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: W.B. Saunders Company; 1994: 701-723
2 Farrell DH, Huang S, Davie EW. Processing of the carboxyl 15-amino acid extension in the α-chain of fibrinogen. J Biol Chem 1993; 268 (14) 10351-10355
3 Brennan SO, Peach RJ. The processing of human proinsulin and chicken proalbumin by rat hepatic vesicles suggests a convertase specific for X-Y-Arg-Arg or Arg-X-Y-Arg sequences. J Biol Chem 1991; 266 (32) 21504-21508
4 Brennan SO, Nakayama K. Cleavage of proalbumin peptides by furin reveals unexpected restrictions at the P2 and P'1 sites. FEBS Lett 1994; 347 (01) 80-84
5 Doolittle RF, Kollman JM. Natively unfolded regions of the vertebrate fibrinogen molecule. Proteins 2006; 63 (02) 391-397
6 Brennan SO, Carrell RW. A circulating variant of human proalbumin. Nature 1978; 274 (5674): 908-909
7 Bentley AK, Rees DJC, Rizza C, Brownlee GG. Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4. Cell 1986; 45 (03) 343-348
8 Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A α 20 Val --> Asp). J Clin Invest 1995; 96 (06) 2854-2858
9 Brennan SO, Mangos H, Faed JM. Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia. Thromb Haemost 2014; 111 (04) 679-684
10 Brennan SO, Brennan S, Laurie AD. Hypofibrinogenaemia associated with novel Aα126Val→Asp mutation in the fibrinogen coiled coil. Thromb Haemost 2017; 117 (10) 2000-2002
11 Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001; 936: 89-90
12 Levrat E, Aboukhamis I, de Moerloose P. , et al. A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family. Blood Coagul Fibrinolysis 2011; 22 (02) 148-150
13 Hanss M, Ffrench P, Vinciguerra C, Bertrand MA, Mazancourt P. Four cases of hypofibrinogenemia associated with four novel mutations. J Thromb Haemost 2005; 3 (10) 2347-2349